Revolutionizing
Neurological Care with
AI-Driven Precision
Using AI to optimize treatments for chronic pain and movement disorders improving patient outcomes and reducing healthcare costs.
MyndLink
AI-Powered Intelligence for Transforming Neurological Treatment
The Problem
Over 50,000 Spinal Cord Stimulators (SCS) are implanted annually1 for chronic pain, but 30% of patients see no improvement2. Since 2019, the cost of SCS procedures has risen to between USD$85,672 and USD$155,748 per patient3, resulting in over $1 billion in annual costs from failed procedures.
1. Pubmed, 2019, 2. Hadanny et al. 2022, 3. Kumar & Bishop, 2009
The Solution
MyndTec is developing MyndLink, an AI-powered software platform that enhances existing neurological treatments by providing personalized insights. This helps healthcare professionals optimize SCS decisions, reduce unnecessary procedures, and save billions of dollars in healthcare and personal costs while enabling regenerative treatments.
MyndTec leverages over a decade of expertise in neurological care and regulatory success to drive AI innovations that transform outcomes and reduce costs.
MyndMove
Our First Product in Neurological Care
MyndMove™ is a non-invasive therapy designed to help patients with paralysis from stroke or spinal cord injury regain movement and improve quality of life. By using electrical signals, MyndMove stimulates the brain to form new neural connections, a process known as neuroplasticity, which aids in recovery and rebuilding strength. Clinical studies show significant improvements in movement and function, even when other treatments have not been effective. Authorized in both the U.S. and Canada, MyndMove offers personalized neuromodulation settings to enhance motor control and sensation.
Cell Regeneration Technology
Repairing the Brain from Within
MyndTec’s cell regeneration technology, currently in preclinical study, uses patients' own neural stem cells, guided by electrical stimulation, to support brain tissue repair and potentially improve outcomes in neurological conditions such as Parkinson’s, stroke, and Alzheimer’s.
